Euphorbia hirta L. as a potential resistance-modifying agent against ESKAPE pathogens: a systematic review
Abstract
Background: The growing issue of antimicrobial resistance (AMR) in bacteria, particularly among the ESKAPE pathogens, has prompted the need to explore additional treatment options. Euphorbia hirta L. (E. hirta) is a botanical drug plant with antimicrobial activities attributed to its biologically active metabolites, namely flavonoids, terpenoids, and phenolic acids.
Methods: This systematic review followed PRISMA guidelines to assess the antimicrobial effects of E. hirta against critical bacterial pathogens. A systematic search and collection of data from 27 peer- reviewed articles on the antimicrobial potential of E. hirta against different bacteria were conducted. Extraction solvents such as ethanol, methanol, petroleum ether, ethyl acetate, chloroform, and water were considered in this systematic review. The antimicrobial potential of E. hirta was assessed using methods such as MIC, MBC, and diffusion assays (disk and well diffusion).
Results: Petroleum ether extract of E. coli, S. aureus, and P. aeruginosa showed the lowest MICs (0.4, 0.125, and 0.4 mg/mL, respectively), while ethanol extracts exhibited potent activity against S. aureus (14.53 mg/mL), K. pneumoniae (19.73 mg/mL), P. aeruginosa (20.06 mg/ mL), and E. faecalis (29 mg/mL). Chloroform extracts showed a relatively constant moderate level of activity against most of the organisms tested. It ranged from 1.45 mg/mL for E. coli and P. aeruginosa. In general, non-polar solvents such as petroleum ether and…
How strong is the evidence?
Evidence Hub reads this as a systematic review. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.